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Abstract
Background: In quality of care research, limited information is found on the relationship between
quality of care and disease outcomes. This case-control study was conducted with the aim to assess
the effect of guideline adherence for stroke prevention on the occurrence of stroke in general
practice. We report on the problems related to a variant of confounding by indication, that may be
common in quality of care studies.
Methods: Stroke patients (cases) and controls were recruited from the general practitioner's (GP)
patient register, and an expert panel assessed the quality of care of cases and controls using
guideline-based review criteria.
Results: A total of 86 patients was assessed. Compared to patients without shortcomings in
preventive care, patients who received sub-optimal care appeared to have a lower risk of
experiencing a stroke (OR 0.60; 95% CI 0.24 to 1.53). This result was partly explained by the
presence of risk factors (6.1 per cases, 4.4 per control), as reflected by the finding that the OR
came much closer to 1.00 after adjustment for the number of risk factors (OR 0.82; 95% CI 0.29
to 2.30). Patients with more risk factors for stroke had a lower risk of sub-optimal care (OR for
the number of risk factors present 0.76; 95% CI 0.61 to 0.94). This finding represents a variant of
'confounding by indication', which could not be fully adjusted for due to incomplete information on
risk factors for stroke.
Conclusions: At present, inaccurate recording of patient and risk factor information by GPs
seriously limits the potential use of a case-control method to assess the effect of guideline
adherence on disease outcome in general practice. We conclude that studies on the effect of quality
of care on disease outcomes, like other observational studies of intended treatment effect, should
be designed and performed such that confounding by indication is minimized.
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There is a long tradition of studying at population level
the quality of medical care provided to patients who died
from conditions amenable to medical intervention. This
type of study (so called 'in-depth' or 'audit' study), aims to
identify deficiencies in medical care that may have con-
tributed to death. It was first systematically carried out on
maternal death, and later on other causes of avoidable
death [1-4]. This method can be applied to other poten-
tially avoidable conditions, e.g. those that could be
avoided by appropriate preventive care. The general
approach is to document in detail the process of care pro-
vided to a single patient preceding the occurrence of an
adverse event, followed by an assessment of the quality of
care by an expert panel, either with or without the use of
explicit criteria [5].
An important limitation of this type of study, without
control subjects, is its inability to fully establish a causal
relationship between identified deficiencies in care and
the adverse outcome, and to determine to what extent
identified deficiencies are associated to the occurrence of
such an event. Identified deficiencies in care are expected
to indicate only to a certain extent an increase in risk of an
adverse health outcome, while the probability of having
an adverse outcome can be calculated only if we compare
the care provided to patients who suffered an adverse out-
come with that of patients who did not suffer such an
event. For this reason it has been proposed to perform a
case-control study with patients with an adverse event as
'cases' and a comparable group of patients without an
adverse outcome as 'controls' [6].
We performed a case-control study with the aim to assess
the effect of guideline adherence for stroke prevention on
the occurrence of stroke in general practice. Unfortu-
nately, we encountered various obstacles in the design
and conduct of this study, in particular related to the
recruitment of cases and controls, in availability of infor-
mation on the care delivery process in the GP's data regis-
tration system, and in controlling for differences other
than differences in the quality of care. The aim of this
paper is to highlight the problems related to a variant of
confounding by indication, that may be common in qual-
ity of care studies.
Observational studies of intended treatment effects are
particularly prone to 'confounding by indication', and can
produce misleading estimates on either, or both, the size
and direction of treatment effects [7,8]. Confounding by
indication refers to an extraneous determinant of the out-
come parameter that is present if a perceived high risk or
poor prognosis is an indication for intervention. This
means that differences in care, for example, between cases
and controls may partly originate from differences in indi-
cation for medical intervention such as the presence of
risk factors for particular health problems. The latter has
frequently been reported in studies evaluating the efficacy
of pharmaceutical interventions [9,10], screening tests
[11], and vaccines [12]. We hypothesise that this may not
only apply to indications for medical intervention but
also for guideline adherence and quality of care. In com-
paring retrospectively the quality of care between patients
with and without a stroke, stroke patients may have
received more preventive care because more indications
for preventive interventions were present. Because differ-
ences in indications for preventive intervention corre-
spond with the probability of an adverse outcome (more
indications will be associated with a higher risk of an
adverse outcome), when comparing care between cases
and controls it is necessary to control for these differences.
If one omits to control for confounding by indication, it
is expected that more and probably better care, correlates
with a higher risk of stroke. In quality of care research,
there is, as yet, little information regarding the role of con-
founding by indication in studies that investigate the
effect of quality of care on disease outcomes.
Methods
Sample
From the Dutch national GP register, a random sample
was taken of 58 GPs working in Rotterdam and the sur-
rounding region. The study was restricted to patients with
a first-ever stroke meeting the following criteria for inclu-
sion: (a) diagnosis of intracerebral haemorrhage or infarc-
tion according to the World Health Organization (WHO)
definition of stroke [13], (b) age between 39–80 year, (c)
occurrence of stroke in the period 1996–1997, (d) stroke
caused by cardiovascular disease (CVD) and not by
trauma, infection or malignancy, (e) presence of hyper-
tension, (f) GP of the patient practising in the southern
part of Rotterdam or surrounding region, (g) patient reg-
istered with local GP for not less than two years, and (h)
patient not living in a nursing home during the two years
period prior to stroke. Cases and controls were selected
from the GPs' patient register, using health outcome
(stroke) and risk factor (e.g. hypertension) entries. For
each case, two controls were randomly selected and
matched with the cases in terms of overall distribution on
sex, age, and hypertension (most important risk factor for
stroke). Cases and controls were not matched on the same
GP.
Data collection
In a pilot study among 32 GPs, the quality of care meas-
urement instruments (audit procedure and question-
naire) were tested. GPs participating in the pilot study did
not participate in this study. Data on the process of care,
two years prior to the occurrence of stroke (for controls
from January 1995 to January 1997), were collected byPage 2 of 7
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using separate questionnaires for each stroke patient. GPs
were interviewed between March and October 1999. At
the time of interview, GPs used either hand-written or
electronic patient records to retrieve patient information.
In case information was not available in the patient's
record, information was drawn from the GP's memory.
For each question, the type of data source was registered.
The questionnaire comprised questions related to patient
characteristics and family and medical history of CVD and
risk factors, and the detection and treatment of cardiovas-
cular risk factors such as hypertension, diabetes mellitus,
transient ischemic attack (TIA) and cardiac failure. Simi-
larly, data were collected on lifestyle-related risk factors
such as smoking status, overweight, and excessive alcohol
intake.
Expert panel and assessment method
The quality of preventive care and its potential to prevent
stroke was assessed and valued by a six-member panel of
experts. The panellists (three neurologists and three GPs)
were selected on the basis of their clinical expertise with
respect to stroke prevention, experience in quality of care
evaluation, academic or non-academic background and
professional discipline. Six practice guidelines relevant to
stroke prevention (hypertension, diabetes mellitus, TIA,
peripheral vascular disease, cardiac failure and angina
pectoris) were selected by the panel [14]. These guide-
lines, based on scientific evidence, broad consensus, and
clinical evidence, are developed and implemented by the
Dutch College of General Practitioners as part of a
national guideline program operational since 1987 [15].
From each guideline, the panellists identified specific ele-
ments of care and systematically converted these into
review criteria (n = 65), allowing detailed measurement of
GP's adherence [16]. All these criteria were all used to con-
struct the patient questionnaire.
In a two-round evaluation, with a final plenary round,
cases were assessed by the panellists (panellists were
divided in sub-panels). Each sub-panel assessed a specific
number of cases. Based on identified elements of sub-
optimal care and seriousness of shortcoming in terms of
'minor' and 'major', the panellists allocated grades on a
scale of 0 to 3 (Table 1).
The two-round process was focussed on detecting consen-
sus among the panellists (providing the same grade), and
no attempt was made to force the panellists to consensus.
The intersubpanel agreement was k = 0.63 (overall agree-
ment on assigned grades between sub-panels was 74%). A
detailed description of the assessment method is provided
elsewhere [17].
Analysis
Analysis of the data was done by using simple cross-tabu-
lations, and by using logistic regression analysis to model
the chance of getting a stroke as a function of the presence
of sub-optimal care (as ascertained by the panel), age and
sex, and risk factors for stroke.
Results
GP Participation and recruitment of cases / controls
The rate of participation was 62% (36 GPs). The main rea-
son for GPs not to participate in the study was lack of time
and interest (68%). Participating and non-participating
GPs did not differ significantly in age, practice type, and
date of qualification. Ninety-two percent of the GPs used
electronic GP information systems. Among cases and con-
trols there was a nonsignificant difference in mean age,
however, cases were slightly older than controls (67 versus
65 years). Initially, before we excluded patients 'without'
hypertension, GPs identified and selected 50 cases and 58
controls (1.4 case and 1.6 control per GP). Expected
number of cases was 2.5 stroke patients per GP per year
Table 1: Grades of (sub)optimal care given by the expert panel (in both groups allpatients are hypertensive)
Cases Controls
n % n %
Grading: 0 No sub-optimal factors have been identified 12 43 18 31
1 Sub-optimal factor(s) have been identified, but are unlikely to be related to the 
occurrence of stroke in this patient
8 29 18 31
2 Sub-optimal factor(s) have been identified, and possibly have failed to prevent 
the stroke in this patient
4 14 18 31
3 Sub-optimal factor(s) have been identified, and are likely to have failed to 
prevent the stroke in this patient
4 14 4 7
Sub-optimal care Grading 1, 2, 3 16 57 40 69
Total Grading 0, 1, 2, 3 28 100 58 100Page 3 of 7
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cases and 58 controls with hypertension entered the
study.
Availability of data
Overall, data for verification of the initial diagnosis of
stroke, assessment of GPs' guideline adherence, and
judgement of the causality of the relationship between
non-adherence and the occurrence of stroke could be col-
lected from the patient records. However, information on
risk factors such as family history of CVD, body weight
(overweight), excessive alcohol intake, and smoking was
less easily obtained. Depending on the type of risk factor,
in 8–56% of all subjects, information on risk factors was
unknown to the GP (8% in patients with overweight, 11%
in patients smoking cigarettes, 17% in patients with exces-
sive alcohol consumption, and 56% in patients with a
family history of CVD). In 41–58% information was
taken from the GP's memory, instead of the patient
register.
Indications for confounding by indication
In 43% of the cases and 31% of the controls, no sub-opti-
mal care could be identified (grade 0), whereas in 57%
and 69%, respectively, sub-optimal care was identified
(grade 1, 2 or 3). Thus the Odds Ratio for a case to receive
sub-optimal care was 0.60 (95%CI 0.24 – 1.53) compared
to a control (Table 1). Compared with controls receiving
sub-optimal care, the number of shortcomings in care per
case receiving sub-optimal care was higher (28/16 = 1.7
versus 41/40 = 1.0) (Table 2). The percentage of short-
comings in hypertensive care, however, was considerably
higher among controls (90% versus 57%, respectively).
The latter, apparently, correlates with the fact that controls
less often have risk factors other than hypertension (next
paragraph).
The mean number of risk factors among cases (6.1 per
patient) was higher than among controls (4.4 per patient)
(Figure 1). Multivariate logistic regression indicates that
cases receiving sub-optimal care (grade 1, 2, or 3) have a
lower risk of stroke (crude OR 0.60) (Table 3). If adjusted
for sex and age distribution, the odds ratio does not
change significantly (adjusted OR 0.64). Subsequently, in
an attempt to investigate the possible role of confounding
by indication we adjusted for risk factor prevalence.
Indeed, with an adjusted OR of 0.82 (95% CI 0.29–2.30),
it seems that risk factor prevalence to some extent explains
why patients receiving sub-optimal care have a lower risk
of stroke.
Patients with a higher number of risk factors for stroke,
indeed have a lower risk of sub-optimal care (OR for the
number of risk factors present 0.76; 95% CI 0.61–0.94).
As expected, higher numbers of risk factors per patient
also increases the risk of stroke (OR for the number of risk
factors present 1.34; 95% CI 1.10–1.62).
Table 2: Guideline-derived elements of care used to indicate shortcomings in care among stroke patients and controls
Practice guideline Elements of care Cases Controls
Arguments derived from practice guideline: Hypertension - Detection of hypertension 1 2
- Confirmation diagnosis hypertension 2 1
- Pharmacologic therapy (anti-hypert. med) 2 1
- Follow-up (quarterly) 8 17
- Follow-up (annually) 3 16
Arguments derived from practice guideline: Diabetes mellitus - Follow-up (quarterly) 4 3
- Laboratory evaluation 1 0
- Referral to eye specialist 1 0
Arguments derived from practice guideline: TIA - Treatment (therapy and follow-up after TIA) 1 1
Arguments derived from more than one practice Guideline - Advice to quit smoking 2 0
- Dietary advice (overweight) 1 0
- Evaluation of cardiovascular risk profile 2 0
Total number of shortcomings 28 41
Total number of patients with shortcomings 16 40
TIA, Transient Ischemic Attack
Note: each patient could have more than one element of sub-optimal carePage 4 of 7
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Risk factor distribution. Prevalence (%) of risk factors for stroke among stroke patients (n = 28) and controls (n = 58). Total 
number of risk factors among stroke patients is 172, and among controls 277. Mean number of risk factors per case is 6.1, and 
for controls 4.4. This relationship is statistically borderline significant (p = 0.096), and could be an explanation for the somehow 
surprising result found earlier, that is, that cases receive sub-optimal care less often than controls.
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This study demonstrated confounding by indication in a
case-control study analysing the association between
guideline adherence and the occurrence of stroke in gen-
eral practice. It also provided insight into the possibilities
for controlling for this confounding bias. We learned that,
at present, difficulties in patient recruitment and data
retrieval seriously limit the potential use of a case-control
method to assess the relationship between guideline
adherence for stroke prevention and stroke in general
practice.
We found that in specific domains data were incomplete
and not readily available in the patient records. As a con-
sequence, in many cases GPs were unable to identify
stroke patients from their patient register, which most
likely introduced under-reporting of stroke patients. As
compared to national frequencies (2.5 stroke patients per
GP per year) [18], GPs participating in our study identi-
fied less stroke patients, 1.7 stroke patient per GP. The
same applies to information on patients' family history of
CVD and lifestyle-related risk factors, which was inaccu-
rate and in many cases not available in the patient's regis-
ter. The latter finding is consistent with previous work on
the accuracy of information on CVD risk factors in GPs'
patient records [19,20], indicating that data from GP's
record on lifestyle-related risk factors of CVD are fre-
quently incomplete or absent. Incomplete information on
risk factors for stroke is a serious threat to the validity of
the results of case-control studies investigating the rela-
tionship between process of care and health care out-
come. It complicates evaluation of GP's adherence to
recommended guidelines, and makes it difficult, if not
impossible, to control for confounding by indication.
Apart from that, information on risk factors that was avail-
able in the patient records is presumably not 100% valid.
Strong indications for the existence of confounding by
indication were found, albeit different from how it is usu-
ally described in literature. Confounding by indication,
which is conceived as a substantial problem in observa-
tional studies of treatment efficacy, usually refers to a sit-
uation in which patients who are more in need both
receive more care have a higher risk of adverse health out-
come [8]. In our study, we show that confounding by
indication can also cause patients with an adverse health
outcome (stroke) to appear to receive better quality of
care.
A more detailed analysis showed, similar to results found
in previous studies, that this result partly emanates from a
higher prevalence of risk factors for stroke among patients
suffering stroke at a later stage in life, which not only
increases the risk of stroke but also GPs' compliance to
guidelines. We hypothesize that, on average, patients with
more risk factors for stroke receive more attention or visit
their GP more frequently, which in turn facilitates
guideline adherence (e.g. compliance to quarterly follow-
up of treated hypertensive patients) and at the same time
results in better quality of care. Controlling for (recorded)
risk factors reduced the counter-intuitive result by approx-
imately one half, and we hypothesise that incomplete reg-
istration of risk factors for stroke explains why the risk of
stroke in stroke-prone or high-risk patients associated
with sub-optimal care remained below 1.00, even after
controlling for risk factors. We hope that our paper draws
the attention of quality of care researchers to this variant
of confounding by indication, that may lead to biased
associations between process measures of quality of care
and care outcomes.
Conclusions
This study shows that, at present, difficulties in patient
recruitment and data retrieval seriously limit the potential
use of a case-control method to assess the relationship
between guideline adherence for stroke prevention and
stroke in general practice. It demonstrates the role of con-
founding by indication, causing patients with an adverse
health outcome to appear to receive better quality of care.
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Table 3: Relationship between quality of care and the occurrence 
of stroke(Odds Ratio and 95% CI)
MODEL 1 MODEL 2 MODEL 3
Care:
Optimal 1.00 (ref.) 1.00 (ref.) 1.00 (ref.)
Sub-optimal 0.60 (0.24–1.53) 0.64 (0.25–1.65) 0.82 (0.29–2.30)
Sex:
Male 1.00 (ref.) 1.00 (ref.)
Female 0.90 (0.36–2.30) 0.61 (0.22–1.72)
Age: 1.03 (0.98–1.08) 1.03 (0.98–1.08)
Risk factors: 0.76 (0.61–0.94)
Note: to control for risk factors, the number of risk factors per 
patient were included in the regression model.Page 6 of 7
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